tiprankstipranks
Trending News
More News >
Origin Therapeutics Holdings, Inc. (TSE:SPLY)
:SPLY
Canadian Market

Origin Therapeutics Holdings, Inc. (SPLY) Cash flow

Compare
3 Followers

Origin Therapeutics Holdings, Inc. Cash Flow

TSE:SPLY's free cash flow for Q3 2024 was $―. For the 2024 fiscal year, TSE:SPLY's free cash flow was decreased by $― and operating cash flow was $-497.23K. See a summary of the company’s cash flow.
Cash Flow
Sep 23Sep 22Sep 21
Operating Cash Flow
$ -924.14K$ -983.68K$ -311.51K
Investing Cash Flow
$ ―$ ―$ ―
Financing Cash Flow
$ ―$ ―$ ―
End Cash Position
$ ―$ ―$ ―
Free Cash Flow
$ ―$ ―$ -311.51K
Currency in USD

Origin Therapeutics Holdings, Inc. Cash Flow